
zzso zzso zzso an zzso gut hormone, is rapidly emerging as a new therapeutic agent for the treatment of diabetes zzso zzso released from zzso zzso is renowned for its potent stimulation of insulin zzso and release from pancreatic zzso zzso administration of zzso to subjects with type 2 diabetes results in the zzso of plasma zzso zzso in part, as a result of zzso zzso insulin zzso However, it is now recognized that zzso has several other zzso actions that collectively improve the type 2 diabetic zzso and may also prove beneficial in the treatment of type 1 zzso These effects include the zzso of gastric zzso and promotion of zzso thereby reducing the availability of nutrients for zzso and reducing the requirement for insulin zzso zzso also reduces plasma zzso levels by suppressing zzso zzso from pancreatic zzso and potentially by improving insulin sensitivity in peripheral zzso zzso zzso zzso expression of zzso genes zzso zzso insulin, and zzso and promotes zzso zzso and differentiation of zzso cells into insulin zzso zzso Although initial clinical trials indicate zzso has excellent therapeutic potential, its relatively short-lived biological activity and delivery difficulties limit its zzso Several approaches that are currently being explored to overcome these limitations include zzso zzso zzso release, preserving the biological activity of the native zzso and developing zzso zzso with extended zzso of zzso 

